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104a Sunday, February 16, 2014measure of oligomerization in contrast to the complex environment of cellular
membranes.
We developed a miniaturized bioassay that allowed us to quantify GPCR olig-
omerization at the level of single proteoliposomes [4]. We employed confocal
microscopy to monitor immobilized single proteoliposomes loaded with fluo-
rescently labeled GPCRs, and measured the oligomerization efficiency as the
Fo¨rster Resonance Energy Transfer (FRET) between donor and acceptor
labeled receptors. This assay was used to probe the homo-oligomerization
properties of two prototypical GPCRs, the cannabinoid receptor 1 (CB1) (5)
and the photoreceptor opsin (6, 7). We anticipate our quantitative single proteo-
liposome assay will provide unique details on GPCR homo-oligomerization un-
obscured by ensemble averaging and cellular complexity.
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The GluD2 receptor is a member of the ionotropic glutamate receptor (iGluR)
superfamily and is expressed in cerebellar Purkinje cells (PCs). GluD2 recep-
tors recognize the neurotransmitters D-serine, but lack excitatory ligand-gated
ion channel activity. Recently, D-serine activity mediated via GluD2 has been
shown to modulate cerebellar long-term-depression (LTD). The intracellular C-
terminal domain (CTD) of GluD2 is required for D-serine regulation. A work-
ing hypothesis for this regulation is that D-serine binding to the extracellular
ligand-binding domain is translated to intracellular rearrangement of the
CTD and hereby potentially affects protein-protein interactions (PPIs) with
intracellular scaffolding proteins or signaling enzymes involved in expression
of cerebellar LTD. Various interacting partners of the GluD2 CTD have been
identified; including the PDZ-domain containing scaffolding protein S-
SCAM and Delphilin and the tyrosine kinase PTPMEG. Furthermore, the
CTD contains multiple phosphorylation sites, which may regulate PPIs.
In the present study, our aim is to study the potential regulation of GluD2 PPIs
by phosphorylation and D-serine. For this purpose, we have established a biolu-
minescence resonance energy transfer (BRET) assay that enables measurement
of GluD2 PPIs in intact cells by inserting the resonance energy donor Renilla
luciferase 8 (Rluc8) at various positions in full-length GluD2 or the isolated
CTD and acceptor molecule green fluorescence protein 2 (GFP2) to known
GluD2 interaction partners.
For PSD95, Delphilin, AP-4 and S-SCAM, it was possible to detect robust
BRET between GluD2 and GFP2-tagged full-length interacting partners as
well as truncated versions containing the isolated PDZ domain. Hereby, an
experimental platform has been created for studying GluD2 PPIs in intact cells.
Results from ongoing characterizations of the influence of CTD phosphoryla-
tion and D-serine ligand-binding on PPIs will be presented.
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Bacterial chemotaxis receptors serve as an ideal model system for elucidating
molecular mechanisms of transmembrane signaling, due to the experimental
accessibility and established biochemical characterization of these proteins.
A gap in the structural understanding of bacterial chemotaxis is present be-
tween electron microscopy of the intact arrays of receptor complexes found
in cells and high-resolution crystal structures of individual proteins and trun-
cated complexes. To bridge this gap we have initiated multidimensional
solid-state NMR spectroscopy studies of a kinase-active ternary complex
composed of the soluble 30 kDa cytoplasmic fragment (CF) of the aspartate
chemoreceptor, the 70 kDa histidine kinase CheA, and the 18 kDa adaptor pro-tein CheW. We prepared uniformly 13C & 15N labeled CF and obtained both
homonuclear and heteronuclear correlation spectra of frozen and unfrozen
complexes.
The initial data indicates that such experiments are feasible on this functional
multi-protein complex. A number of narrow resonances with sub-ppm line-
widths are observed in spectra of both frozen and unfrozen samples, and
both states exhibit sufficient signal-to-noise for acquiring multidimensional
spectra. Overall, the spectra demonstrate the strongly overlapping resonances
expected for an alpha-helical 30 kDa protein, which suggests selective labeling
for future measurements of structural constraints. For these samples containing
uniformly labeled receptor fragment, comparison with predicted chemical shift
spectra are being used to test the current structural model. Comparisons of
frozen and unfrozen spectra are also being used to assess the presence of static
disorder or dynamics in the side chain and backbone resonances. The goal for
uniformly labeled receptor samples is to compare spectral properties of both
signaling states to gain insight into possible differences in structure and
dynamics.
This research supported by NIH grant GM085288.
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Excitotoxic calcium signaling, a hallmark of aberrant neuronal activity during
cerebral ischemia and brain trauma, induces a loss of CaMKII activity that ap-
pears to sensitize neurons to glutamate-induced toxicity. Because CaMKII is
present in astrocytes and other glia, we postulate that aberrant CaMKII
signaling could compromise neuronal signaling and survival to excitotoxicity
by disrupting astrocyte function. In support of this model, inhibition of CaMKII
in cortical astrocytic cultures with a peptide (tat-CN21) as well as a small mole-
cule (KN-93) inhibitor significantly reduces glutamate uptake compared to
inactive controls, suggesting that glutamate transporters in astrocytes require
CaMKII for their basal activity. The two primary excitatory amino acid
transporters (EAAT) in astrocytes are EAAT 1 and EAAT2. Co-
immunoprecipitation from rodent brain and immunocytochemical studies in
cortical astrocytes reveal an association and co-localization respectively be-
tween EAAT2 and CaMKII. Although additional studies are required to deter-
mine if these interactions exist for EAAT1 and CaMKII in cells, in vitro studies
using GST-fusion proteins and peptide tiling arrays indicate that purified
dCaMKII binds to the N terminal and second intracellular loop of EAAT1,
whereas, CaMKII preferentially binds to the N terminus and third intracellular
loop of EAAT2. Using P32 incorporation as an index of CaMKII phosphoryla-
tion, phosphorylation of immunoprecipitated transporters as well as peptide
tiling assays for EAAT2 reveal that astrocytic glutamate transporters are indeed
CaMKII substrates. In total, our data support the hypothesis that astrocytic
glutamate transporters are regulated by CaMKII binding and/or phosphoryla-
tion. Further studies are required to determine if a loss of CaMKII activity
that is associated with pathological states, including epilepsy and ischemic
stroke, compromises neuronal survival due to reduced glutamate transporter
function previously associated with excitotoxicity.
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G protein-coupled receptors (GPCRs) are heptahelical transmembrane proteins
that are highly susceptible to their lipid environment. Reconstitution of GPCRs
into detergent micelles or liposomes allows researchers to control the lipid
environment. Yet, micelle and liposome preparations are in homogeneous
and protein incorporation is difficult to control. To address these issues, nano-
scale apolipoprotein bound bilayers (NABBs), soluble phospholipid bilayers
stabilized by the helical protein apolipoprotein A-I derived from zebra fish
(zap1), have been previously devised. Yet, our approach has been limited by
the poor expression of zap1 in E. coli. [1] To increase expression of zap1,
we designed a synthetic gene (zapN1) with a codon-optimized sequence encod-
ing the same amino acid sequence as zap1. We transformed BL21-Gold (DE3)
cells with the zapN1 gene and performed a double-screen of protein expression
from single transformed colonies. We show that zapN1 expresses in a shaking
culture at higher levels than the native gene and the membrane scaffold protein
MSP1D1 from Stephen Sligar’s group. We carefully parameterized the induc-
tion and temperature values, finding that induction at an OD600 of 0.8 with
Sunday, February 16, 2014 105a1 mM IPTG and 3 hours incubation at 30 C yields the highest protein yield per
ml of culture. We also show that a batch purification procedure of zapN1 using
the His60 Ni superflow resin yields highly pure zapN1. The optimized protocol
is easy to implement and requires no extensive preparation with fermenter or
FPLC purification. The exceptional purity and high yield of the procedure
makes it attractive for single-molecule fluorescence assays, such as fluores-
cence (cross-) correlation spectroscopy and total internal reflection fluores-
cence microscopy, and structural studies. [1] AM Knepp, A Grunbeck, S
Banerjee, TP Sakmar, T Huber (2011) Direct measurement of thermal stability
of expressed CCR5 and stabilization by small molecule ligands. Biochemistry,
50, 502-511.
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Muscarinic receptors (MR) are G protein-coupled receptors (GPCRs). Local-
ized to the plasma membrane, they sense changes of the membrane potential
and exhibit voltage-dependent signaling. Because voltage activates Gq-coupled
receptors (e.g. M1R) but deactivates Gi-coupled receptors (e.g. M2R), it was
proposed that GPCRs which couple to the same G protein class share common
voltage-dependent properties. In this study we analyzed signaling of the Gq
protein-coupled M1R, M3R and M5R with fluorescence resonance energy trans-
fer (FRET) microscopy and voltage clamp. To test whether Gq protein coupling
influences voltage sensitivity, we expressed a biosensor that reports conforma-
tions of M1R in HEK 293 cells and analyzed Carbachol (CCh)-induced receptor
activation at 90 mV and at þ60 mV. Depolarization caused activation of
M1R, which was not abolished after uncoupling of Gq proteins with GTPgS.
A FRET assay that reports activation of Gq was then used to compare wild
type M1R, M3R and M5R. Application of CCh induced robust activation of
Gq at 90 mV for all three receptors. Subsequent depolarization revealed
subtype-specific phenotypes: at þ60 mV the Gq protein was either activated
(M1R) or deactivated (M3R or M5R). Voltage sensitivity of MR was also influ-
enced by the nature of the activating agonist: M3R displayed deactivation
(CCh) or activation (Pilocarpine) at þ60 mV. Computational docking studies
predicted different molecular binding modes for each agonist and guided us
to select key point mutations in the orthosteric binding site of muscarinic recep-
tors. Further docking of mutant M3R predicted a novel ‘‘Pilocarpine-like’’
binding mode for CCh. Subsequent experiments confirmed that mutant M3R
were indeed activated by voltage in the presence of CCh. Together, these re-
sults imply that the molecular mechanism by which GqPCRs sense voltage re-
sides in the receptor protein with negligible contribution of G protein coupling.
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The ability of sodium ions to increase the binding of antagonists and decrease the
binding of agonistswas first suggested for opioid receptors (ORs) in the ’70s, and
subsequently extended to other G protein-coupled receptors (GPCRs). These
early conclusions derived from saturation analyses of ligand binding, using brain
tissue homogenates with or without sodium. Further studies in tissues suggested
differential regulation by sodium ions, with kappa sites being less sensitive to
sodium thanmu- and delta-opioid receptor sites. Our latest experiments in stable
transfected cell lines demonstrate that a) agonist binding tomu, delta and kappa1
receptors is equally sensitive to sodium ions, and b) sodium ions tend to stabilize
the antagonist conformation of the receptor. To provide a molecular-level
understanding of these findings, we carried out microsecond-scale, all-atom
standardmolecular dynamics simulations of recent high-resolution crystal struc-
tures of ORs in an explicit 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC)-water environment at high sodium concentration. In spite of significant
differences in sodium ion density around unique negatively charged residues in
the extracellular region of kappa receptors, these simulations reveal similar rapid
permeation of a sodium ion from the receptor extracellular sides, and its stable
binding to the highly conserved residue D2.50. Notably, very high-resolution,
crystal structures of GPCRs have recently provided direct evidence for sodium
binding to an equivalent site involving residueD2.50.Although a second sodium
ion is found to bind quite stably to a unique glutamic acid in the extracellular
portion of transmembrane helix 6 of the kappa receptor (a lysine in mu and a
tryptophan in delta), principal component analyses of our simulations suggest
a similarly stabilized conformation of ORs by sodium.557-Pos Board B312
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It is well established that aberrant activation of the Epidermal Growth Factor
Receptor (EGFR) drives cellular transformation and oncogenesis. A series of
activating mutations in the extracellular region of EGFR have been identified
in glioblastoma multiforme (GBM) patients, and shown to transform NIH 3T3
cells. Sedimentation equilibrium analytical ultracentrifugation analysis dem-
onstrates that, in the context of the soluble EGFR extracellular region
(sEGFR), these mutations are monomeric in the absence of ligand and
dimerize upon ligand binding with affinities that are similar to those observed
for the wildtype receptor. We also find that these mutations elevate the affinity
of growth factor binding to sEGFR, and that there are differential effects on
the entropic driving forces of growth factor binding to sEGFR. Taken
together, these results demonstrate a potentially novel mode of EGFR disre-
gulation by these GBM mutations. Our recent detailed thermodynamic anal-
ysis of ligand binding and dimerization in the EGFR system suggests that a
greater understanding of the changes that occur upon binding of ligand to
EGFR will be required before we can appreciate the mechanisms of disregu-
lation by oncogenic mutation. We will present our progress towards deter-
mining a profile of the dynamic and conformational effects of ligand
binding to EGFR using associated hydrogen/deuterium exchange coupled to
mass spectrometry (HX/MS). Comparing these profiles to those for EGFR
bearing oncogenic mutations may reveal why these single amino acid substi-
tutions can lead to receptor activation. Progress towards the application of
these techniques to near full length receptors reconstituted in a lipid nanodisc
model membrane system will also be reported, which will provide valuable
information about the structurally poorly characterized juxtamembrane re-
gions of EGFR.
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The endogenous cannabinoid ligand, 2-arachidonoylglycerol (2-AG), is a
lipid-derived signaling molecule that activates cannabinoid receptors in brain
and peripheral tissues. Because of high lipophilicity, 2-AG readily partitions
into lipid bilayers. Molecular behavior of 2-AG in bilayers and mechanism
of approach to the receptor binding-pocket remain unsolved; approach via
lateral diffusion in lipid matrix was suggested according to microsecond-
long molecular dynamics simulations. We studied location, structure, dy-
namics, and kinetics of acyl-chain migration (2-AG/1-AG) of 2-AG in lipid
bilayers of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) by
solid-state NMR and neutron diffraction. Binding of 2-AG to purified CB2 re-
ceptor functionally reconstituted into liposomes was probed by 2H magic-
angle-spinning NMR of headgroup-deuterated 2-AG (2-AG-d5). The
exponential-decay constant of 2-AG due to acyl-chain migration at physiolog-
ical temperature was determined to be 43 min, while molecular characteriza-
tion of 2-AG was achieved by investigating the temperature-dependence. 1H
cross-relaxation rates measured in two-dimensional NOESY revealed that
the double-bond region of the arachidonoyl chain (20:4) of 2-AG locates
with high probabilities at the upper methylene segments of POPC, with a sig-
nificant distribution around glycerol. The data agrees with neutron diffraction,
exhibiting highest probabilities of those double bonds near the hydrophobic-
hydrophilic interface. The arachidonoyl chain shows high flexibility in lipid bi-
layers. In the presence of CB2,
2H resonances of 2-AG-d5 shifted upfield with
line-broadening. The upfield shift was absent when the pocket was blocked
with a high affinity agonist like CP-55,940, demonstrating specificity of 2-
AG interaction with the CB2 binding-pocket. The induced shift suggests a
model of rapid exchange of 2-AG between free and CB2-bound states; discus-
sions regarding other possibilities will be presented. The enrichment of 2-AG
in lipid bilayers and the conformational flexibility of 2-AG are likely to be crit-
ical for an efficient interaction with CB2.
